Michael Kranda

Background

About Michael Kranda

Background | Board & Product to Market Details | Skills | Patents Served in Executive, Operational, and Board roles for numerous private and public companies. Led multiple private rounds, IPOs, and M&A transactions, and product approvals. Passionate about driving growth, innovation and value creation. Summary of Board of Director Roles - Aclipse Therapeutics - NCE's for ALS and gastroparesis - Life Sprout Therapeutics - nano tech for tissue engineering and cell therapy applications - BEAT Bio - Cardio vascular gene therapy - PTC Therapeutics, also Chairman of Audit Committee - NCE's for rare diseases - Allen Brain Science Institute - Open source non-profit brain research institute - BiPar - PPAR molecule for the treatment triple negative breast cancer - Oxford GlycoSciences (OGS)- Proteomics platform plus approved product for Gaucher disease - Immunex - Pioneering immunology biotech Products Development Achievements / Approved Products - Leukine: Neutropenia - Enbrel : RA - TransLarna: DMD - Everysdi: Spinal muscular atrophy - Vevesca: Gaucher and Niemann Skills - Gene Therapy - Cell Therapy - Oncology - CNS - Orphan drugs - AI enabled cell- imaging - Manufacturing and Regulatory Affairs - Turnaround Situations - Leadership and Recruiting - Fundraising and BD - Board work and Governance - Venture Capital Patents - Co-inventor on an application using machine learning algorithms and neural networks for non invasive 3D cell imaging in the production of cellular therapy's.